Skip Navigation

This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow References
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Hering, D.
Right arrow Articles by Horstkotte, D.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Hering, D.
Right arrow Articles by Horstkotte, D.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?


Management of prosthetic valve thrombosis

D. Hering1, C. Piper and D. Horstkotte

Department of Cardiology, Heart Center North Rhine-Westphalia, Ruhr University, Bad Oeynhausen, Germany

1 Correspondence: Detlef Hering, MD, Department of Cardiology, Heart Center North Rhine-Westphalia, Ruhr University, Bad Oeynhausen, Georgstraße 11, D-32545 Bad Oeynhausen, Germany.

Abstract

Fibrinolysis and surgery with either valvular re-replacement or thrombectomy are both established therapies for prosthetic valve thrombosis. In both treatment strategies, the complication rate depends to a similar degree on pre-interventional clinical and haemodynamic status. Fibrinolysis serves to avoid a second operation, but the incidence of recurrent thrombosis is higher. Before deciding in favour of thrombolytic therapy, structural defects of the prosthetic valve or tissue in-growth, which increase the risk of rethrombosis, should be ruled out by transoesophageal echocardiography. Apart from those cases in which there are contraindications to either treatment, we recommend surgery in cases of underlying prosthetic valve dysfunction or recurrent thrombosis.

Key Words: Prosthetic valve thrombosis • thrombectomy • thrombolytic therapy • valve replacement


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Eur Heart JHome page
Endorsed by the European Society of Intensive Care, Authors/Task Force Members, M. S. Nieminen, M. Bohm, M. R. Cowie, H. Drexler, G. S. Filippatos, G. Jondeau, Y. Hasin, J. Lopez-Sendon, et al.
Executive summary of the guidelines on the diagnosis and treatment of acute heart failure: The Task Force on Acute Heart Failure of the European Society of Cardiology
Eur. Heart J., February 2, 2005; 26(4): 384 - 416.
[Full Text] [PDF]

Home page
 Eur. J. Cardiothorac. Surg.Home page
R. Roudaut, X. Roques, S. Lafitte, E. Choukroun, N. Laborde, F. Madona, C. Deville, and E. Baudet
Surgery for prosthetic valve obstruction. A single center study of 136 patients
Eur. J. Cardiothorac. Surg., December 1, 2003; 24(6): 868 - 872.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
J. S. Alpert
The thrombosed prosthetic valve: Current recommendations based on evidence from the literature,*
J. Am. Coll. Cardiol., February 19, 2003; 41(4): 659 - 660.
[Full Text] [PDF]


Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.